These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 35034257)

  • 1. Research advances in the role and pharmaceuticals of ATP-binding cassette transporters in autoimmune diseases.
    Yu J; Chen H; Xu J; Zhou P
    Mol Cell Biochem; 2022 Apr; 477(4):1075-1091. PubMed ID: 35034257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer.
    van de Ven R; Oerlemans R; van der Heijden JW; Scheffer GL; de Gruijl TD; Jansen G; Scheper RJ
    J Leukoc Biol; 2009 Nov; 86(5):1075-87. PubMed ID: 19745159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in the targeting ATP-binding cassette transporters to overcome tumor multi-drug resistance].
    Wei N; Sun H; Liu GT
    Yao Xue Xue Bao; 2010 Oct; 45(10):1205-11. PubMed ID: 21348297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of DMARDs on the expression and function of P-gp, MRPs, BCRP in the treatment of autoimmune diseases.
    Wu YJ; Wang C; Wei W
    Biomed Pharmacother; 2018 Sep; 105():870-878. PubMed ID: 30021380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability and applications of ATP-binding cassette (ABC) transporter blockers.
    Ponte-Sucre A
    Appl Microbiol Biotechnol; 2007 Aug; 76(2):279-86. PubMed ID: 17522856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory potential of tuberculosis drugs on ATP-binding cassette drug transporters.
    Te Brake LH; Russel FG; van den Heuvel JJ; de Knegt GJ; de Steenwinkel JE; Burger DM; Aarnoutse RE; Koenderink JB
    Tuberculosis (Edinb); 2016 Jan; 96():150-7. PubMed ID: 26682943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of ABC Transporters in Drug Development.
    Nwabufo CK
    Curr Drug Metab; 2022; 23(6):434-446. PubMed ID: 35726814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade.
    Chen Z; Shi T; Zhang L; Zhu P; Deng M; Huang C; Hu T; Jiang L; Li J
    Cancer Lett; 2016 Jan; 370(1):153-64. PubMed ID: 26499806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2.
    Shukla S; Robey RW; Bates SE; Ambudkar SV
    Drug Metab Dispos; 2009 Feb; 37(2):359-65. PubMed ID: 18971320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ABC transporters in cancer chemotherapy.
    Sun YL; Patel A; Kumar P; Chen ZS
    Chin J Cancer; 2012 Feb; 31(2):51-7. PubMed ID: 22257384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer.
    Chen Y; Bieber MM; Teng NN
    Mol Carcinog; 2014 Aug; 53(8):625-34. PubMed ID: 23423781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research Progress on the Role of ABC Transporters in the Drug Resistance Mechanism of Intractable Epilepsy.
    Xiong J; Mao DA; Liu LQ
    Biomed Res Int; 2015; 2015():194541. PubMed ID: 26491660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR.
    Mohammad IS; He W; Yin L
    Biomed Pharmacother; 2018 Apr; 100():335-348. PubMed ID: 29453043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversing agents for ATP-binding cassette drug transporters.
    Lee CH
    Methods Mol Biol; 2010; 596():325-40. PubMed ID: 19949930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.
    Schinkel AH; Jonker JW
    Adv Drug Deliv Rev; 2003 Jan; 55(1):3-29. PubMed ID: 12535572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP-binding cassette transporters in tumor endothelial cells and resistance to metronomic chemotherapy.
    Hida K; Kikuchi H; Maishi N; Hida Y
    Cancer Lett; 2017 Aug; 400():305-310. PubMed ID: 28216371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving cancer chemotherapy with modulators of ABC drug transporters.
    Shukla S; Ohnuma S; Ambudkar SV
    Curr Drug Targets; 2011 May; 12(5):621-30. PubMed ID: 21039338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR).
    Lee CH
    Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):43-52. PubMed ID: 14754411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erlotinib antagonizes ABC transporters in acute myeloid leukemia.
    Lainey E; Sébert M; Thépot S; Scoazec M; Bouteloup C; Leroy C; De Botton S; Galluzzi L; Fenaux P; Kroemer G
    Cell Cycle; 2012 Nov; 11(21):4079-92. PubMed ID: 23095522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.